89bio Inc Stock Today
ETNB Stock | USD 11.64 0.33 2.92% |
Performance1 of 100
| Odds Of DistressLess than 9
|
89bio is trading at 11.64 as of the 29th of March 2024, a 2.92 percent up since the beginning of the trading day. The stock's open price was 11.31. 89bio has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for 89bio Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of April 2022 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 11th of November 2019 | Category Healthcare | Classification Health Care |
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. The company has 93.5 M outstanding shares of which 11.11 M shares are currently shorted by private and institutional investors with about 6.67 trading days to cover. More on 89bio Inc
Moving together with 89bio Stock
0.83 | MDGL | Madrigal Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
Moving against 89bio Stock
0.53 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
0.44 | ME | 23Andme Holding | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
89bio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. 89bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding 89bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Average Analyst Recommendation Analysts covering 89bio report their recommendations after researching 89bio's financial statements, talking to executives and customers, or listening in on 89bio's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering 89bio Inc. The 89bio consensus assessment is calculated by taking the average forecast from all of the analysts covering 89bio. | |||||
89bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to 89bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand 89bio's financial leverage. It provides some insight into what part of 89bio's total assets is financed by creditors.
|
89bio Inc (ETNB) is traded on NASDAQ Exchange in USA. It is located in 142 Sansome Street, San Francisco, CA, United States, 94104 and employs 70 people. 89bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate 89bio's market, we take the total number of its shares issued and multiply it by 89bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. 89bio Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 93.5 M outstanding shares of which 11.11 M shares are currently shorted by private and institutional investors with about 6.67 trading days to cover.
89bio Inc currently holds about 193.34 M in cash with (129.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.16.
Check 89bio Probability Of Bankruptcy
Ownership Allocation89bio Inc retains a total of 93.5 Million outstanding shares. The majority of 89bio Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in 89bio Inc to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in 89bio. Please pay attention to any change in the institutional holdings of 89bio Inc as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check 89bio Ownership Details
89bio Stock Price Odds Analysis
What are 89bio's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of 89bio jumping above the current price in 90 days from now is about 32.45%. The 89bio Inc probability density function shows the probability of 89bio stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.2756 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, 89bio will likely underperform. Additionally, 89bio Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
Based on a normal probability distribution, the odds of 89bio to move above the current price in 90 days from now is about 32.45 (This 89bio Inc probability density function shows the probability of 89bio Stock to fall within a particular range of prices over 90 days) .
89bio Stock Institutional Holders
Institutional Holdings refers to the ownership stake in 89bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of 89bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing 89bio's value.Instituion | Recorded On | Shares | |
Bvf Inc | 2023-09-30 | 1.8 M | |
Westfield Capital Management Company, Lp | 2023-12-31 | 1.8 M | |
Braidwell Lp | 2023-09-30 | 1.6 M | |
Citadel Advisors Llc | 2023-09-30 | 1.5 M | |
Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.5 M | |
Geode Capital Management, Llc | 2023-12-31 | 1.4 M | |
Goldman Sachs Group Inc | 2023-12-31 | 1.3 M | |
Octagon Capital Advisors Lp | 2023-09-30 | 1.2 M | |
Laurion Capital Management Lp | 2023-09-30 | 1.2 M | |
Ra Capital Management, Llc | 2023-12-31 | 11.4 M | |
Hhg Plc | 2023-12-31 | 8.9 M |
89bio Historical Income Statement
89bio Inc Income Statement is one of the three primary financial statements used for reporting 89bio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of 89bio Inc revenue and expense. 89bio Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, 89bio's Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.9 M, whereas Tax Provision is forecasted to decline to 10,000. View More Fundamentals89bio Stock Against Markets
Picking the right benchmark for 89bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in 89bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for 89bio is critical whether you are bullish or bearish towards 89bio Inc at a given time. Please also check how 89bio's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in 89bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
89bio Corporate Management
Elected by the shareholders, the 89bio's board of directors comprises two types of representatives: 89bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 89bio. The board's role is to monitor 89bio's management team and ensure that shareholders' interests are well served. 89bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 89bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Harry MD | Chief Officer | Profile | |
Rohan Palekar | CEO Director | Profile | |
Quoc LeNguyen | Chief Quality | Profile | |
Shiva CPA | Senior Officer | Profile | |
Shiva Natarajan | Senior Officer | Profile | |
Amanda Hill | VP Culture | Profile | |
Melissa Abel | VP Communications | Profile |
How to buy 89bio Stock?
Before investing in 89bio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in 89bio. To buy 89bio stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of 89bio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase 89bio stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located 89bio Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased 89bio Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as 89bio Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy 89bio Stock please use our How to Invest in 89bio guide.
Already Invested in 89bio Inc?
The danger of trading 89bio Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of 89bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than 89bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile 89bio Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
CEOs Directory Screen CEOs from public companies around the world |
Is 89bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.00) | Return On Assets (0.24) | Return On Equity (0.41) |
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.